Metric | Before Implementation | After Implementation | P-value |
---|---|---|---|
Total Patients Analyzed | 50 | 50 | Â |
Patients aged > 50 years | 32 (64%) | 27 (54%) | 0.309 |
Patients with Diabetes | 21 (42%) | 17 (34%) | 0.409 |
Patients with UTIs | 12 (24%) | 4 (8%) | 0.029 |
Recurrent UTIs | 8 (16%) | 3 (6%) | N/A |
Total UTI Episodes | 20 | 7 | 0.003 |
Average Episodes per Patient | 5.2 | 2 | N/A |
Patients with UTIs within first 6 months | 14/20 (70%) | 5/7 (71%) | 0.11 |
Total number of Readmissions due to UTIs/year | 10 (20%) | 4 (8%) | 0.083 |
Average Hospital Admissions per Patient | 3.5 | 0.5 | N/A |
Average Length of Hospital Stay (Days) | 8 | 4 | 0.218 |
Induction Therapy: Thymoglobulin | 3 (6%) | 2 (4%) | 0.646 |
Induction Therapy: Basiliximab | 47 (94%) | 48 (96%) | 0.646 |
Nursing Staff Training Hours/year | 10 | 40 | N/A |
Nursing Training Completion Rates | 32 (64%) | 45 (90%) | 0.002 |
Patient Education Sessions/year | None | 12 | N/A |
Patient Education Session Attendance | 25 (50%) | 42 (84%) | 0.0003 |
Patient Satisfaction Scores | 35 (70%) | 45 (90%) | 0.012 |
Quality of Life Assessments | 32 (64%) | 40 (80%) | 0.074 |
Follow-Up Compliance Rate | 25 (50%) | 42 (84%) | 0.0003 |
Healthcare Costs Per Admission | $10,000 | $6,000 | N/A |